SARS-CoV-2 Virus-like Particles Produced by a Single Recombinant Baculovirus Generate Anti-S Antibody and Protect against Variant Challenge

Coronavirus Disease 2019 (COVID-19), caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has highlighted the need for the rapid generation of efficient vaccines for emerging disease. Virus-like particles, VLPs, are an established vaccine technology that produces vi...

詳細記述

書誌詳細

出版年:	Viruses
主要な著者:	Edward Sullivan, Po-Yu Sung, Weining Wu, Neil Berry, Sarah Kempster, Deborah Ferguson, Neil Almond, Ian M. Jones, Polly Roy
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2022-04-01
主題:	SARS COVID-19 coronavirus baculovirus VLP recombinant
オンライン･アクセス:	https://www.mdpi.com/1999-4915/14/5/914